Vijaya Diagnostic Centre Stock Screener | Share Price & Fundamental Analysis
VIJAYA
Healthcare Service Provider
Screen Vijaya Diagnostic Centre share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1031.20
▼
-17.50 (-1.67%)
Share Price BSE
₹1029.75
▼
-18.85 (-1.80%)
Market Cap
₹10,708.00 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
12.36
EPS (TTM)
₹13.95
Dividend Yield
0.19%
Debt to Equity
0.40
52W High
₹1241.80
52W Low
₹891.20
Operating Margin
39.00%
Profit Margin
19.55%
Revenue (TTM)
₹179.00
EBITDA
₹73.00
Net Income
₹35.00
Total Assets
₹1,274.00
Total Equity
₹799.00
Vijaya Diagnostic Centre Share Price History - Stock Screener Chart
Screen VIJAYA historical share price movements with interactive charts. Analyze price trends and patterns.
Vijaya Diagnostic Centre Company Profile - Fundamental Screener
Screen Vijaya Diagnostic Centre company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VIJAYA shares.
Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across 20 cities in India, offering laboratory services, radiology and imaging, cardiology, neurology, and gastroenterology services. In 2021, Vijaya Diagnostic Centre Limited went public with an IPO of Rs 1895.04 crore and its shares were listed on the BSE and NSE.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
Chairperson/CEO
Sura Surendranath Reddy
ISIN
INE043W01024
Website
https://www.vijayadiagnostic.com
Vijaya Diagnostic Centre Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen VIJAYA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 1,274 | 983 | 853 | 714 | 541 | 482 | 301 | 234 |
| Current Assets | 307 | 211 | 276 | 270 | 239 | 186 | 138 | 103 |
| Fixed Assets | 865 | 742 | 524 | 371 | 268 | 272 | 151 | 119 |
| Liabilities | ||||||||
| Total Liabilities | 1,274 | 983 | 853 | 714 | 541 | 482 | 301 | 234 |
| Current Liabilities | 312 | 250 | 241 | 178 | 138 | 150 | 40 | 33 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 799 | 660 | 547 | 470 | 359 | 274 | 211 | 161 |
| Share Capital | 10 | 10 | 10 | 10 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 786 | 647 | 535 | 458 | 355 | 270 | 204 | 155 |
Screen VIJAYA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 179 | 195 | 208 | 159 | 160 | 188 | 174 | 126 | 127 | 146 | 138 | 119 | 107 | 124 | 117 |
| Expenses | 105 | 115 | 120 | 92 | 95 | 107 | 102 | 72 | 73 | 82 | 82 | 68 | 65 | 72 | 69 |
| EBITDA | 73 | 81 | 88 | 66 | 65 | 81 | 72 | 54 | 54 | 64 | 55 | 51 | 43 | 52 | 48 |
| Operating Profit % | 39.00% | 39.00% | 41.00% | 41.00% | 39.00% | 42.00% | 40.00% | 41.00% | 40.00% | 41.00% | 38.00% | 41.00% | 38.00% | 40.00% | 39.00% |
| Depreciation | 19 | 21 | 22 | 16 | 17 | 17 | 18 | 11 | 13 | 14 | 15 | 15 | 14 | 16 | 20 |
| Interest | 7 | 8 | 8 | 6 | 6 | 7 | 7 | 6 | 6 | 6 | 6 | 4 | 5 | 5 | 6 |
| Profit Before Tax | 47 | 52 | 58 | 44 | 42 | 57 | 47 | 37 | 36 | 45 | 35 | 31 | 24 | 31 | 22 |
| Tax | 13 | 14 | 15 | 10 | 10 | 15 | 11 | 9 | 9 | 11 | 9 | 8 | 6 | 8 | 6 |
| Net Profit | 35 | 39 | 43 | 34 | 32 | 42 | 35 | 28 | 26 | 34 | 26 | 24 | 18 | 24 | 17 |
| EPS | 3.38 | 3.76 | 4.21 | 3.27 | 3.06 | 4.10 | 3.42 | 2.69 | 2.57 | 3.26 | 2.53 | 2.33 | 1.71 | 2.29 | 1.60 |
Vijaya Diagnostic Centre Cash Flow Screener - Liquidity Fundamentals
Screen VIJAYA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 225 | 183 | 165 | 158 | 130 | 106 | 91 | 62 |
| Investing Activities | -182 | -141 | -110 | -123 | -130 | -31 | -90 | -98 |
| Financing Activities | -52 | -45 | -42 | -31 | -49 | -30 | -7 | -8 |
| Net Cash Flow | -9 | -2 | 13 | 4 | -49 | 46 | -7 | -44 |
Screen VIJAYA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.60% | 52.63% | 53.05% | 53.91% | 53.91% | 53.93% | 54.06% | 54.87% |
| FII Holding | 18.27% | 19.56% | 19.36% | 17.54% | 18.14% | 20.08% | 20.09% | 0.00% |
| DII Holding | 25.34% | 24.07% | 23.72% | 24.63% | 23.46% | 21.49% | 20.80% | 19.55% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 3.20% | 3.24% | 3.42% | 3.43% | 3.94% | 3.98% | 4.38% | 4.63% |
| Other Holding | 0.59% | 0.50% | 0.45% | 0.49% | 0.55% | 0.52% | 0.67% | 20.95% |
| Shareholder Count | 58,994 | 62,115 | 66,891 | 60,952 | 62,258 | 62,415 | 66,724 | 66,204 |
Vijaya Diagnostic Centre Dividend Screener - Share Yield Analysis
Screen VIJAYA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 0.19% |
| 2024-March | ₹1.00 | 0.10% |
| 2023-March | ₹1.00 | 0.16% |
| 2022-March | ₹1.00 | 0.25% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Vijaya Diagnostic Centre Index Membership - Market Screener Classification
Screen VIJAYA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Vijaya Diagnostic Centre Market Events Screener - Corporate Actions
Screen VIJAYA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 3.68% | ||
| Dividend | ₹ 1.00 /share | 25.94% | ||
| Dividend | ₹ 1.00 /share | 3.49% | ||
| Annual General Meeting | NA | 15.76% | ||
| 2025-11-25 | 2025-11-25 | Merger - Demerger | 22:1 | 0.00% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 3.04% |
| 2025-08-29 | 2025-08-29 | Dividend | ₹ 2.00 /share | -0.04% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 2.38% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -2.35% |
| 2025-04-25 | 2025-04-25 | Extraordinary General Meeting | NA | 1.00% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.14% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 4.96% |
| 2024-08-30 | 2024-08-30 | Dividend | ₹ 1.00 /share | 33.84% |
Vijaya Diagnostic Centre Competitors Screener - Peer Comparison
Screen VIJAYA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 25,297 | 46.83 | 2,555 | 11.28% | 492 | 60.03 |
| Vijaya Diagnostic Centre | 10,708 | 70.34 | 700 | 23.06% | 144 | 57.20 |
| Metropolis Healthcare | 9,830 | 61.96 | 1,346 | 10.64% | 146 | 46.81 |
| Thyrocare Technologies | 7,110 | 56.28 | 702 | 20.80% | 91 | 48.33 |
| Nephrocare Health Services | 4,574 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,402 | 28.37 | 743 | 16.70% | 78 | 48.50 |
| Suraksha Diagnostic | 1,423 | 45.66 | 256 | 15.11% | 31 | 41.02 |
| One Global Service Provider | 1,263 | 28.65 | 148 | 134.60% | 19 | 59.79 |
| 3B BlackBio DX | 1,214 | 24.67 | 112 | 28.72% | 48 | 57.22 |
| Sastasundar Ventures | 938 | -103.51 | 1,171 | -18.47% | -134 | 38.32 |
Vijaya Diagnostic Centre Company Announcements - News Screener
Screen VIJAYA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Closure of Trading Window | View |
| 2025-12-05 | Cancellation Of Analyst / Institutional Investor Meeting Dated December 08 2025. | View |
| 2025-12-05 | Reply On Clarification Sought By BSE Limited Regarding Increase In The Volume Of The Security Across Exchanges. | View |
| 2025-12-05 | Clarification sought from Vijaya Diagnostic Centre Ltd | - |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-04 | Noting Of Wholly Owned Subsidiary - Medinova Millennium MRI Services LLP Pursuant To Scheme Of Amalgamation | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-11-04 | Corporate Action - Fixation Of Record Date On November 25 2025. | View |
| 2025-11-04 | Unaudited Financial Results For The Second Quarter And Half Year Ended September 30 2025. | View |
| 2025-11-04 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Nov 04 2025 | View |
| 2025-10-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-27 | Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled On 04/11/2025 Inter Alia To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Second Quarter And Half Year E | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |